In this real-world study of patients with type 2 diabetes, treatment with semaglutide resulted in greater reductions in body weight and hemoglobin A1c than dulaglutide.
Allison Spitery, PharmD, BCACP
Advertisement
Articles by Allison Spitery, PharmD, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
2
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
3
How Often Do Health Insurers Deny Doctor-Recommended Care?
4
Sudden Death in HFpEF Often Preceded by Clinical Decline
5